Valtrex and Osteoporosis - a phase IV clinical study of FDA data
Osteoporosis is found among people who take Valtrex, especially for people who are female, 50-59 old, have been taking the drug for 1 - 2 years.
The phase IV clinical study analyzes which people take Valtrex and have Osteoporosis. It is created by eHealthMe based on reports of 32,398 people who have side effects when taking Valtrex from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
32,398 people reported to have side effects when taking Valtrex.
Among them, 302 people (0.93%) have Osteoporosis.
What is Valtrex?
Valtrex has active ingredients of valacyclovir hydrochloride. It is often used in genital herpes. eHealthMe is studying from 34,253 Valtrex users for its effectiveness, alternative drugs and more.
What is Osteoporosis?
Osteoporosis (bones weak and more likely to break) is found to be associated with 2,333 drugs and 1,762 conditions by eHealthMe.
Number of Valtrex and Osteoporosis reports submitted per year:
Time on Valtrex when people have Osteoporosis *:
Gender of people who have Osteoporosis when taking Valtrex*:
Age of people who have Osteoporosis when taking Valtrex *:
Common drugs people take besides Valtrex *:
Common side effects people have besides Osteoporosis *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Valtrex and have Osteoporosis?Check whether Osteoporosis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
- Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
Alternative drugs to, pros and cons of Valtrex:
- Valtrex (34,253 reports)
Osteoporosis treatments and more:
- Osteoporosis (254,672 reports)
COVID vaccines that are related to Osteoporosis:
- Osteoporosis in Moderna COVID Vaccine
- Osteoporosis in Pfizer BioNTech Covid Vaccine
- Osteoporosis in Johnson and Johnson Covid Vaccine
How severe was Osteoporosis and when was it recovered:
Expand to all the drugs that have ingredients of valacyclovir hydrochloride:
Common drugs associated with Osteoporosis:
All the drugs that are associated with Osteoporosis:
- Osteoporosis (2,333 drugs)
Common conditions associated with Osteoporosis:
All the conditions that are associated with Osteoporosis:
- Osteoporosis (1,762 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on valacyclovir hydrochloride (the active ingredients of Valtrex) and Valtrex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.